Govt Job Portal to get info about latest Govt Jobs in India.10th, 12th pass Govt jobs.Best courses after 12th class. Defense ...

The speakers discuss Netflix’s architecture for surviving extreme traffic spikes. They explain the mechanics of prioritized ...

For many financial institutions, the first phase of enterprise AI adoption has followed an all too familiar script. Connect a large language model to internal data, layer on retrieval tools, and ...

The U.S. Food and Drug Administration (FDA) on June 11 issued an Emergency Use Authorization (EUA) for generic nitenpyram tablets for the treatment of New World screwworm (NWS) infestations (myiasis) ...

Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...

Save big with discount apps: Prescription discount apps like GoodRx, Cost Plus Drugs, and SingleCare can often beat your insurance price, saving consumers hundreds of dollars. Shop around before every ...

The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...

A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s ...

In recent weeks, Canada became the first G7 country to approve a generic version of the popular drug Ozempic. Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to ...

See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google Emerge from a ...

TrumpRx’s sevenfold formulary expansion positions a government-backed portal as a high-volume generics price aggregator rather than a dispensing pharmacy. Tariff exemptions tied to three-year ...

Americans are unlikely to see generic versions of semaglutide — the active ingredient in Novo Nordisk’s Ozempic and Wegovy — until at least the end of 2031, according to a May 13 NBC News report. Novo ...